Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test
Read More General business news Flexiroam stock holds at A$0.007 as CFO appointment raises hopes for a microcap turnaround Flexiroam (ASX: FRX) holds at A$0.007 as it appoints a new CFO. Find out how tighter finance and a global eSIM footprint could drive a microcap re-rating today. byShanvithaSeptember 30, 2025